Skip to main content
. 2006 Mar 16;573(Pt 2):427–443. doi: 10.1113/jphysiol.2006.105882

Table 2.

Relative potency and maximal effects of several nucleotide agonists on vasodilation and NO release in human placental cotyledon

Dilatation NO release


EC50 (nm) Emax (%) EC50 (nm) Emax (pmol)
2-MeSATP 4.2 ± 0.7 68 ± 13 (4) 83 ± 8 353 ± 51 (5)
2-MeSADP 7.2 ± 0.6 75 ± 9 (5) 27 ± 4 201 ± 33 (4)
UTP 86 ± 7 56 ± 7 (5) 1843 ± 124 120 ± 17 (4)
UDP >10 000 12 ± 7 (4) ≫10 000 14 ± 5 (4)
ATP 322 ± 21 57 ± 8 (5) ≫10 000 <5 (4)

Values in parenthesis indicate the number of experiments performed.